Table 2. Frequency of Molecular Aberrations.
| No. of patients | % | |
|---|---|---|
| # of patients consented for molecular analysis | 428 | 100 |
| # of specimens quality control passed | 407 | |
| No. of aberrations detected for AmpliSeq | ||
| 0 | 65 | 15.9 |
| 1 | 141 | 34.6 |
| 2 | 123 | 30.2 |
| 3 | 51 | 12.5 |
| ≥4 | 27 | 6.6 |
| No. of patients with at least one aberrations by AmpliSeq alone | 342 | 84.1 |
| # of specimens available for both Ampliseq and 21-gene copy number variation array | 281 | |
| No. of aberrations detected for AmpliSeq and 21-gene copy number variation array* | ||
| 0 | 41 | 14.6 |
| 1 | 79 | 28.1 |
| 2 | 81 | 28.8 |
| 3 | 51 | 18.1 |
| ≥4 | 29 | 10.3 |
*
N = 407 Ampliseq 2.0 + 21-gene copy number variation array; N = 281, Ampliseq 2.0 available